Foravisét to Present at LSX Investival Showcase London 2026
Foravisét will take the stage at LSX Inve$tival Showcase London on November 16, 2026. CEO J.J. Marx will present on the Biotech Growth Showcase Stage, while he and Board Chairperson Mindy Gross will engage with international life-sciences investors and strategic partners throughout London Life Sciences Week.
Foravisét Named Lead Research Partner for the 2026 U.S. Women's Health Infrastructure Report
Foravisét is proud to serve as the Exclusive Lead Research Partner for the 2026 U.S. Women's Health Infrastructure Report, developed with Women's HealthX. The report examines the systemic barriers holding back women's healthcare innovation—from gaps in clinical evidence and research to reimbursement, access, and the adoption of new therapies.
Foravisét at Women's HealthX 2026: Platinum Sponsor
Foravisét is proud to serve as a Platinum Sponsor of Women's HealthX 2026 in Boston, December 3–4. Our CEO, J.J. Marx, will chair the Evidence, Data & Innovation track, while Chief Scientific Officer Dr. Yuval Kaufman will present on the role of iNOS in endometriosis. We look forward to connecting with investors, pharmaceutical partners, and women's health innovators throughout the conference.